Approved Blood Test
CST now produces and manufactures an approved cancer blood test for Colorectal cancer and a TPD (Canada) approved blood test for Lung Cancer. Please note: at this time the products are not available in the USA.
Over a period of nine years CST integrated three sets of products and two science backgrounds to combine them with our distinct disciplines on five different continents to create an unprecedented and completely revolutionary cancer blood test that can now detect 20 major cancers.
There are no other regulatory-approved pan (multiple) tumour cancer tests on the market anywhere in the world today.
Our blood cancer test is approximately 30% more accurate than any other commercial cancer blood test available in the market today.
Our blood cancer test was the first new cancer test for Colorectal Cancer to be approved by the FDA in 31 years, (since January 14, 1982).
Our blood cancer test also has had TPD approval in Canada, the CE mark in Europe, TGA in Australia, and is licensed and imported as a non-approved general cancer screen in Brazil, India, South Korea, Taiwan, and Vietnam.
We have had;
- TGA in Australia, CE mark in Europe, TPD in Canada, and 4 import certifications in South Korea, India, Taiwan and Vietnam for our blood test.
- International Patent protection and Patents pending.
We are:
- The only company in the world with a Diagnostic cancer test that can detect almost ALL major cancers.
- The only company in the world with a commercial IVD cancer test that can detect Lung Cancer. (The number 1 cancer in the world)
- The only company in the world with a commercial IVD cancer test that can detect Nasopharyngeal Carcinoma (‘NPC’ – cancer of the Nose & Throat). (The number 4 cancer in China)
- The only company in the world with a commercial IVD cancer test that is predictive of the stage of a cancer.